Bettina Hederer

Tiotropium versus Salmeterol for the Prevention of Exacerbations of COPD

Claus Vogelmeier, Bettina Hederer, Thomas Glaab et al. · New England Journal of Medicine · 2011 · 681 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Higher lung deposition with Respimat Soft Mist inhaler than HFA-MDI in COPD patients with poor technique.

Peter Brand, Bettina Hederer, George Austen et al. · PubMed · 2008 · 98 citations · Full text

Pharmacy, Clinical Sciences, Nuclear Medicine +17

Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial

Richard Beasley, James F. Donohue, Rajendra H. Mehta et al. · BMJ Open · 2015 · 30 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

A randomized, double-blind study to compare the efficacy and safety of two doses of mometasone furoate delivered via Breezhaler® or Twisthaler® in patients with asthma

Roland Buhl, Ana-Maria Tanase, Motoi Hosoe et al. · Pulmonary Pharmacology & Therapeutics · 2020 · 16 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Indacaterol acetate/mometasone furoate provides sustained improvements in lung function compared with salmeterol xinafoate/fluticasone propionate in patients with moderate-to-very-severe COPD: results from a Phase II randomized, double-blind 12-week study

Kai Michael Beeh, Anne‐Marie Kirsten, Ana-Maria Tanase et al. · International Journal of COPD · 2018 · 13 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17